• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Beam Therapeutics Inc (NQ: BEAM )

    24.72 -0.93 (-3.63%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Sep 23, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,034,023
    Open 25.81
    Bid (Size) 24.10 (1)
    Ask (Size) 24.93 (10)
    Prev. Close 25.65
    Today's Range 24.47 - 25.82
    52wk Range 16.95 - 49.50
    Shares Outstanding 79,199,501
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Deep Dive Into Beam Therapeutics Stock: Analyst Perspectives (6 Ratings)
    Via Benzinga
    A Closer Look at 5 Analyst Recommendations For Beam Therapeutics
    Via Benzinga

    Performance

    YTD
    -9.81%
    -9.81%
    1 Month
    -7.80%
    -7.80%
    3 Month
    -0.44%
    -0.44%
    6 Month
    -26.63%
    -26.63%
    1 Year
    +7.43%
    +7.43%

    More News

    Read More
    Gene Editing Korro Bio's Preclinical Data 'Best-In-Class', Analyst Initiates With Outperform Rating
    Via Benzinga
    3 Gene Editing Stocks with Potential to Transform Medicine
    Via InvestorPlace
    BEAM Stock Earnings: Beam Therapeutics Beats EPS, Misses Revenue for Q2 2024
    Via InvestorPlace
    Beam Therapeutics Reports Pipeline Updates and Second Quarter 2024 Financial Results
    From Beam Therapeutics
    Via GlobeNewswire
    ViaSat & AST SpaceMobile Are Among Top 6 Mid Cap Stocks That Shined The Brightest Last Week (July 21-July 27): Are The Others In Your Portfolio?
    Via Benzinga
    IBM Posts Upbeat Earnings, Joins ServiceNow, Helmerich & Payne, RTX, Nasdaq And Other Big Stocks Moving Higher On Thursday
    Via Benzinga
    Beam Therapeutics Stock Earns RS Rating Jump To 85
    Via Investor's Business Daily
    Why Is Conn’s (CONN) Stock Down 36% Today?
    Via InvestorPlace
    Topics Bankruptcy
    Exposures Financial Legal
    Trade of the Day: Buy Beam Therapeutics Call Options as BEAM Stock Heads to $40
    Via InvestorPlace
    Danaher Posts Upbeat Earnings, Joins Spotify, MSCI, Owens & Minor And Other Big Stocks Moving Higher On Tuesday
    Via Benzinga
    3 Gene Editing Stocks Shaping the Future of Medicine
    Via InvestorPlace
    Cathie Wood-Led Ark Invest Sells $8M In Tesla Shares Despite Bullish Autonomy Forecast
    Via Benzinga
    Beam Therapeutics Announces Transition of Chief Financial Officer
    From Beam Therapeutics
    Via GlobeNewswire
    The 3 Most Undervalued Gene Editing Stocks to Buy in July 2024
    Via InvestorPlace
    3 Stocks With the Potential to 10X Your Money
    Via InvestorPlace
    FDA Favorites: 3 Biotech Stocks on the Verge of Major Approvals
    Via InvestorPlace
    Exposures Product Safety
    3 Stocks This Amazon-Backed AI Says Will Turn $1K into $1M by 2030
    Via InvestorPlace
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    You’ve Been Warned! 3 Gene Editing Stocks to Buy Now or Regret Forever.
    Via InvestorPlace
    Beam Therapeutics Announces First Patient Dosed in the Phase 1/2 Study of BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD)
    From Beam Therapeutics
    Via GlobeNewswire
    Beam Therapeutics Reports Data Highlighting Optimized Manufacturing Process for BEAM-101, an Investigational Base Editing Therapeutic for Sickle Cell Disease
    From Beam Therapeutics
    Via GlobeNewswire
    Beam Therapeutics to Participate in Jefferies Global Healthcare Conference
    From Beam Therapeutics
    Via GlobeNewswire
    Beam Therapeutics to Present Data Highlighting Robust Manufacturing Process for BEAM-101 at 2024 European Hematology Association (EHA) Hybrid Congress
    From Beam Therapeutics
    Via GlobeNewswire
    Biotech Breakthroughs: 3 Stocks on the Verge of Revolutionizing Medicine
    Via InvestorPlace
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.